{
  "pmcid": "11916589",
  "sha256": "a23fb19b7c385ddbdf60bda961d6bd490577632478b15fcd1d970bc6c5b77d15",
  "timestamp_utc": "2025-11-09T15:26:08.594321+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.901781609195407,
    "reading_ease": 35.55887931034485,
    "word_count": 261
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Fluid management is challenging and still remains controversial in orthotopic liver transplantation (OLT)."
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "Twenty‐five patients were enrolled in this study."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Fluid loading (10 mL/kg colloid) was performed at two different phases during the operation, and fluid responsiveness was defined as an increase in CI TPTD ≥ 15%."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study was designed to examine whether the PVI can reliably predict fluid responsiveness in OLT and to compare PVI with other hemodynamic indexes that are measured using the PiCCO 2 monitoring system."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Fluid responsiveness was defined as an increase in CI TPTD ≥ 15%."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Twenty‐five patients were enrolled in this study."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Area under the curve for PVI was 0.56 (sensitivity 35%, specificity 90%, p = 0.58) at dissection phase, and was 0.55 (sensitivity 55%, specificity 66%, p = 0.58) at anhepatic phase."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 9,
    "max_score": 25
  }
}